BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34883528)

  • 1. Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities.
    Gaborit M; Massotte D
    Br J Pharmacol; 2023 Apr; 180(7):994-1013. PubMed ID: 34883528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies towards safer opioid analgesics-A review of old and upcoming targets.
    Varga BR; Streicher JM; Majumdar S
    Br J Pharmacol; 2023 Apr; 180(7):975-993. PubMed ID: 34826881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid research in the time of the opioid crisis.
    Traynor JR; Moron JA
    Br J Pharmacol; 2023 Apr; 180(7):793-796. PubMed ID: 36813266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo opioid receptor heteromerization: where do we stand?
    Massotte D
    Br J Pharmacol; 2015 Jan; 172(2):420-34. PubMed ID: 24666391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the mechanisms underlying opioid use disorder and potential treatment strategies.
    Cao DN; Li F; Wu N; Li J
    Br J Pharmacol; 2023 Apr; 180(7):862-878. PubMed ID: 34128238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
    Fujita W; Gomes I; Devi LA
    Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging areas of opioid pharmacology.
    Kelly E; Henderson G; Bailey CP
    Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.
    Lee MT; Mackie K; Chiou LC
    Br J Pharmacol; 2023 Apr; 180(7):894-909. PubMed ID: 34877650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dynamic interaction between pain and opioid misuse.
    Wilson-Poe AR; Morón JA
    Br J Pharmacol; 2018 Jul; 175(14):2770-2777. PubMed ID: 28602044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders.
    Alvarez-Perez B; Poras H; Maldonado R
    Br J Pharmacol; 2023 Apr; 180(7):879-893. PubMed ID: 34378790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects.
    López-Cano M; Font J; Aso E; Sahlholm K; Cabré G; Giraldo J; De Koninck Y; Hernando J; Llebaria A; Fernández-Dueñas V; Ciruela F
    Br J Pharmacol; 2023 Apr; 180(7):958-974. PubMed ID: 34363210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anomalous pharmacology of fentanyl.
    Kelly E; Sutcliffe K; Cavallo D; Ramos-Gonzalez N; Alhosan N; Henderson G
    Br J Pharmacol; 2023 Apr; 180(7):797-812. PubMed ID: 34030211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and countering opioid-induced respiratory depression.
    Bateman JT; Saunders SE; Levitt ES
    Br J Pharmacol; 2023 Apr; 180(7):813-828. PubMed ID: 34089181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.
    Fujita W; Gomes I; Devi LA
    Br J Pharmacol; 2014 Sep; 171(18):4155-76. PubMed ID: 24916280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of knockout mice to clarify the role of the opioid system in chronic pain.
    Maldonado R; Baños JE; Cabañero D
    Br J Pharmacol; 2018 Jul; 175(14):2791-2808. PubMed ID: 29124744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel GPCR paradigms at the μ-opioid receptor.
    Thompson GL; Kelly E; Christopoulos A; Canals M
    Br J Pharmacol; 2015 Jan; 172(2):287-96. PubMed ID: 24460711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures.
    Marino KA; Shang Y; Filizola M
    Br J Pharmacol; 2018 Jul; 175(14):2834-2845. PubMed ID: 28266020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinase.
    Groom S; Blum NK; Conibear AE; Disney A; Hill R; Husbands SM; Li Y; Toll L; Kliewer A; Schulz S; Henderson G; Kelly E; Bailey CP
    Br J Pharmacol; 2023 Apr; 180(7):943-957. PubMed ID: 33245558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement of current opioid drugs focusing on MOR-related strategies.
    Busserolles J; Lolignier S; Kerckhove N; Bertin C; Authier N; Eschalier A
    Pharmacol Ther; 2020 Jun; 210():107519. PubMed ID: 32165137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allostery at opioid receptors: modulation with small molecule ligands.
    Livingston KE; Traynor JR
    Br J Pharmacol; 2018 Jul; 175(14):2846-2856. PubMed ID: 28419415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.